Coronavirus: Thread

grarpamp grarpamp at
Wed Jun 1 19:38:09 PDT 2022

More retractions and endless caveats regarding questionable efficacy
and need for big-pharma's wonder-vax and wonder-drugs.
Pharma still hasn't released fully unredacted testing data,
they say it will take years and years for that, lol.

CDC Director Issues Alert On Pfizer's COVID-19 Pill

Authored by Jack Phillips via The Epoch Times,

Centers for Disease Control and Prevention Director Rochelle Walensky
warned that Pfizer’s COVID-19 pill Paxlovid can lead to a rebound in

    “If you take Paxlovid, you might get symptoms again,” Walensky
told CBS News on Tuesday.

    “We haven’t yet seen anybody who has returned with symptoms
needing to go to the hospital. So, generally, a milder course.”

Another researcher who is not affiliated with the CDC said that he has
observed such a scenario.

“People who experience rebound are at risk of transmitting to other
people, even though they’re outside what people accept as the usual
window for being able to transmit,” Dr. Michael Charness of the
Veterans Administration Medical Center in Boston told CNN on Tuesday.

After a patient recovers from COVID-19, the aforementioned rebound has
occurred between two and eight days later, according to the CDC. The
agency, however, told CBS that the benefits of taking Paxlovid
outweigh the risks of COVID-19, namely among those who are at a high
risk of developing severe symptoms from the virus.

A Pfizer technician handles the company’s COVID-19 pill, known as
Paxlovid, in a file photograph. (Pfizer via AP)

About a week ago, the agency issued an alert to health care providers
about the rebound, saying that patients who took Paxlovid either test
positive for the virus after having tested negative or will experience
COVID-19 symptoms.

    “A brief return of symptoms may be part of the natural history of
SARS-CoV-2 infection in some persons, independent of treatment with
Paxlovid and regardless of vaccination status,” the federal health
agency said at the time. SARS-CoV-2 is another name for the CCP
(Chinese Communist Party) virus, which causes COVID-19.

    “Limited information currently available from case reports
suggests that persons treated with Paxlovid who experience COVID-19
rebound have had mild illness; there are no reports of severe disease.
There is currently no evidence that additional treatment is needed
with Paxlovid or other anti-SARS-CoV-2 therapies in cases where
COVID-19 rebound is suspected,” the CDC added.

The Epoch Times has contacted Pfizer for comment. Pfizer told CBS that
it is observing a rebound rate of approximately 2 percent and is
continuing to monitor patients.

    “We have not seen any [COVID-19] resistance emerge to date in
patients treated with Paxlovid,” a spokesperson for the company told
Reuters this week.

In recent weeks, doctors have increasingly prescribed Paxlovid, which
has been authorized to treat at-risk people. But some health care
workers told Reuters they are putting off prescribing the medication.

“I am shying away from giving it to people who are very low- risk, and
are not terribly ill, particularly people who are vaccinated and
boosted,” said Dr. Bruce Farber, chief of public health and
epidemiology for Northwell Health, in an interview with the news
agency. He will still prescribe the bill to people who have
significant health conditions or are aged 75 and older.

More information about the cypherpunks mailing list